LB54640
A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
Rhythm · Phase 2 · Status n/r · Enrollment 4
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| POMC/PCSK1/LEPR cohort | n/r | n/r | n/r | n/r |
Not shown
- POMC/PCSK1/LEPR cohort: endpoint not reported